HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.

By FiercePharma · May 18, 2026 · via FiercePharma
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

Image: FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma

Tags
peopleformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
UPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDA
PeopleFierceBiotech ↗
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator is heading …
May 17, 2026
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
PeopleFiercePharma ↗
Takeda's multiyear slim-down is expected to hit about 4,500 roles during the 2026 fiscal year, resulting in ab…
May 17, 2026
CDER chief Høeg fired from FDA as other top roles turn over
PeopleEndpoints News ↗
The leader of the FDA's drug division, Tracy Beth Høeg, is expected to depart, as part of a broad shakeup at t…
May 15, 2026